Variation in hospital utilization of palliative interventions for patients with advanced gastrointestinal cancer near end of life

被引:4
|
作者
Chen, Vivi W. W. [1 ,2 ]
Portuondo, Jorge I. [2 ]
Cooper, Zara [3 ,4 ]
Massarweh, Nader N. [5 ,6 ,7 ]
机构
[1] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA
[2] Baylor Coll Med, Michael E DeBakey Dept Surg, 2002 Holcombe Blvd,OCL 112, Houston, TX 77030 USA
[3] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA USA
[4] Brigham & Womens Hosp, Dept Surg, Boston, MA USA
[5] Atlanta VA Hlth Care Syst, Surg & Perioperat Care, Decatur, GA USA
[6] Emory Univ, Dept Surg, Div Surg Oncol, Sch Med, Atlanta, GA USA
[7] Morehouse Sch Med, Dept Surg, Atlanta, GA USA
关键词
end of life; gastrointestinal cancer; hospital variation; palliative; CLINICAL-PRACTICE GUIDELINES; MEDICARE BENEFICIARIES; GASTRIC-CANCER; OLDER-ADULTS; CARE; OUTCOMES; TRENDS; ESOPHAGEAL; QUALITY; COLON;
D O I
10.1002/jso.27177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPatients with advanced gastrointestinal (GI) cancer often undergo noncurative interventions with palliative intent to relieve high symptom burden near end of life. Hospital-level variation in intervention utilization remains unclear. MethodsNational cohort study of 142 304 patients with stage III or IV GI cancer within the National Cancer Database (2004-2014) who died within 1-year of diagnosis. Hospitals were stratified by palliative intervention utilization (surgery, chemotherapy, radiation, pain management). Multivariable, multinomial regression evaluated the association between patient/hospital factors and palliative intervention utilization. ResultsAcross 1322 hospitals, median hospital palliative intervention utilization was 12.0% [interquartile range: 0.0%-26.1%]. Utilization increased over time in all but lowest utilizing hospitals. Relative to lowest utilizing hospitals, factors associated with a lower likelihood of care at highest utilizing hospitals included: race (White [ref]; Black-Relative Risk Ratio [RRR] 0.81, 95% confidence interval [0.77-0.85]) and lower income (RRR 0.81 [0.78-0.84]). Factors associated with a higher likelihood included: lower education level (RRR 1.62 [1.55-1.69]) and hospital type (community program [ref]; comprehensive community-RRR 1.33 [1.26-1.41]; academic-RRR 1.88 [1.77-1.99]; integrated network-RRR 1.79 [1.66-1.93]). ConclusionHospital variation in palliative intervention use is substantial and potentially associated with sociodemographic and hospital characteristics. Future work can examine how differences in hospital care processes translate to quantity/quality of life for cancer patients.
引用
收藏
页码:741 / 751
页数:11
相关论文
共 50 条
  • [31] Palliative Medicine Referral and End-of-Life Interventions Among Racial and Ethnic Minority Patients With Advanced or Recurrent Gynecologic Cancer
    Tabuyo-Martin, Angel
    Torres-Morales, Angelica
    Pitteloud, Marie J.
    Kshetry, Alisha
    Oltmann, Carina
    Pearson, Joseph Matthew
    Khawand, Mariana
    Schlumbrecht, Matthew P.
    Sanchez, Julia C.
    [J]. CANCER CONTROL, 2023, 30
  • [32] End of life resource utilization among patients receiving immunotherapy for advanced cancer
    Burkart, J. T.
    Patel, S.
    Noonan, A. M.
    Monk, P.
    Presley, C. J.
    Olencki, T.
    Kendra, K. L.
    Otterson, G. A.
    Gustin, J.
    Wei, L.
    Owen, D. H.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 553 - 553
  • [33] Palliative Care and the Aggressiveness of End-of-Life Care in Patients With Advanced Pancreatic Cancer
    Jang, Raymond W.
    Krzyzanowska, Monika K.
    Zimmermann, Camilla
    Taback, Nathan
    Alibhai, Shabbir M. H.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (03)
  • [34] Duration of palliative care involvement and immunotherapy treatment near the end of life among patients with cancer who died in-hospital
    Auclair, Juline
    Sanchez, Stephane
    Chrusciel, Jan
    Hannetel, Louise
    Frasca, Matthieu
    Economos, Guillaume
    Habert-Dantigny, Raphaelle
    Bruera, Eduardo
    Burucoa, Benoit
    Ecarnot, Fiona
    Colombet, Isabelle
    Barbaret, Cecile
    [J]. SUPPORTIVE CARE IN CANCER, 2022, 30 (06) : 4997 - 5006
  • [35] Duration of palliative care involvement and immunotherapy treatment near the end of life among patients with cancer who died in-hospital
    Juline Auclair
    Stéphane Sanchez
    Jan Chrusciel
    Louise Hannetel
    Matthieu Frasca
    Guillaume Economos
    Raphaelle Habert-Dantigny
    Eduardo Bruera
    Benoit Burucoa
    Fiona Ecarnot
    Isabelle Colombet
    Cécile Barbaret
    [J]. Supportive Care in Cancer, 2022, 30 : 4997 - 5006
  • [36] Palliative Care and Resource Utilization at the End-of-Life in Advanced Liver Disease
    Patel, Arpan
    Walling, Anne
    May, Folasade
    Saab, Sammy
    Wenger, Neil
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S395 - S395
  • [37] The Paradox of Palliative Care at the End of Life: Higher Rates of Aggressive Interventions in Patients with Pancreatic Cancer
    Zhang, Zidong
    Gokul, Kaushik
    Hinyard, Leslie J.
    Subramaniam, Divya S.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [38] Palliative Care is Associated with Reduced Aggressive End-of-Life Care in Patients with Gastrointestinal Cancer
    Shaila J. Merchant
    Susan B. Brogly
    Craig Goldie
    Christopher M. Booth
    Sulaiman Nanji
    Sunil V. Patel
    Katherine Lajkosz
    Nancy N. Baxter
    [J]. Annals of Surgical Oncology, 2018, 25 : 1478 - 1487
  • [39] Palliative Care is Associated with Reduced Aggressive End-of-Life Care in Patients with Gastrointestinal Cancer
    Merchant, Shaila J.
    Brogly, Susan B.
    Goldie, Craig
    Booth, Christopher M.
    Nanji, Sulaiman
    Patel, Sunil V.
    Lajkosz, Katherine
    Baxter, Nancy N.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) : 1478 - 1487
  • [40] Palliative care and end-of-life health care utilization in elderly patients with pancreatic cancer
    Bhulani, Nizar
    Gupta, Arjun
    Gao, Ang
    Li, Jenny
    Guenther, Chad
    Ahn, Chul
    Paulk, Elizabeth
    Houck, Stephanie
    Beg, Muhammad S.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (03) : 495 - 502